Nextleaf Solutions Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Nextleaf Solutions has been growing earnings at an average annual rate of 40.1%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 55.9% per year.
Anahtar bilgiler
40.1%
Kazanç büyüme oranı
47.6%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 23.1% |
| Gelir büyüme oranı | 55.9% |
| Özkaynak getirisi | -17.0% |
| Net Marj | -6.6% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Gelir ve Gider Dağılımı
Nextleaf Solutions nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 12 | -1 | 4 | 0 |
| 31 Mar 24 | 11 | 0 | 3 | 0 |
| 31 Dec 23 | 10 | 1 | 2 | 0 |
| 30 Sep 23 | 8 | 0 | 2 | 0 |
| 30 Jun 23 | 6 | -1 | 2 | 0 |
| 31 Mar 23 | 5 | -3 | 2 | 0 |
| 31 Dec 22 | 4 | -3 | 3 | 0 |
| 30 Sep 22 | 4 | -3 | 3 | 0 |
| 30 Jun 22 | 5 | -5 | 3 | 0 |
| 31 Mar 22 | 4 | -5 | 3 | 0 |
| 31 Dec 21 | 3 | -5 | 3 | 0 |
| 30 Sep 21 | 3 | -5 | 3 | 0 |
| 30 Jun 21 | 2 | -6 | 3 | 0 |
| 31 Mar 21 | 2 | -5 | 3 | 0 |
| 31 Dec 20 | 2 | -6 | 4 | 0 |
| 30 Sep 20 | 1 | -6 | 4 | 0 |
| 30 Jun 20 | 0 | -6 | 5 | 0 |
| 31 Mar 20 | 0 | -6 | 5 | 0 |
| 31 Dec 19 | 0 | -10 | 7 | 0 |
| 30 Sep 19 | 0 | -9 | 6 | 0 |
| 30 Jun 19 | 0 | -8 | 5 | 0 |
| 31 Mar 19 | 0 | -6 | 4 | 0 |
| 31 Dec 18 | 0 | -3 | 2 | 0 |
| 30 Sep 18 | 1 | -2 | 2 | 0 |
| 30 Jun 18 | 0 | -2 | 1 | 0 |
| 30 Sep 17 | 0 | -1 | 0 | 0 |
Kaliteli Kazançlar: OILS is currently unprofitable.
Büyüyen Kar Marjı: OILS is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: OILS is unprofitable, but has reduced losses over the past 5 years at a rate of 40.1% per year.
Büyüme Hızlandırma: Unable to compare OILS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: OILS is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).
Özkaynak Getirisi
Yüksek ROE: OILS has a negative Return on Equity (-17.04%), as it is currently unprofitable.